Enrollment drive for cancer prevention study begins - myFOXlubbock.com

You could potentially be a part of preventing cancer. A local effort is starting up to get Lubbock involved in a national cancer prevention study by the American Cancer Society.

CPS-3, as the 20-year study is known, will enter the recruitment phase locally on April 2 with a kickoff lunch. Businesses and individuals are encouraged to attend by purchasing tickets for $15 or $120 for a table of eight. The featured speaker at the event will be Dr. Tedd Mitchell, president of the Texas Tech University Health Sciences Center.

Read the full story >>

Related Stories

How Does Your Garden Grow?

As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.

Adopt a Growth Mindset for a Better Life

A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.

Drug Use, Family History Can Lead to Heart Disease in Younger Adults

Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.

Recent Stories

Education

TTUHSC School of Medicine Faculty Member Elected to the Texas Medical Association Board of Trustees

The Texas Medical Association (TMA) elected Rodney Young, M.D., to the TMA Board of Trustees during TexMed 2024, its annual conference in Dallas.

Health

Texas Tech Physicians Announces Website Redesign

This May, Texas Tech Physicians announced the launch of its newly redesigned website. TTUHSC experts address a few questions about the new user experience.

Research

TTUHSC’s Ahmed Investigating Cardiac Cell Regeneration

Mahmoud Salama Ahmed, Ph.D., and an international team of researchers have completed an investigation to uncover novel therapeutics or existing therapeutic regimens previously approved by the FDA for cardiac regeneration.